Physician
Radiation Oncology
Dr. Erik P. Sulman, MD
|
|
Give Review
Erik P. Sulman practices Radiation Oncology. He researched medicine at Temple University School of Medicine. Erik Sulman is a published doctor. He published 51 publications, including: 'Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-B-dependent Manner.' He accepts Medicare payments and is listed with Medicare.gov.
Publications
- Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner.
- Mir-21-Sox2 Axis Delineates Glioblastoma Subtypes with Prognostic Impact.
- Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapy.
- IDH mutation status and role of WHO grade and mitotic index in overall survival in grade II-III diffuse gliomas.
- EZH2 protects glioma stem cells from radiation-induced cell death in a MELK/FOXM1-dependent manner.
- Systematic Identification of Single Amino Acid Variants in Glioma Stem-Cell-Derived Chromosome 19 Proteins.
- Use of ENCODE Resources to Characterize Novel Proteoforms and Missing Proteins in the Human Proteome.
- Mitotic Index is an Independent Predictor of Recurrence-Free Survival in Meningioma.
- Two mature products of MIR-491 coordinate to suppress key cancer hallmarks in glioblastoma.
- A randomized trial of bevacizumab for newly diagnosed glioblastoma.
- Dosimetric predictors of duodenal toxicity after intensity modulated radiation therapy for treatment of the para-aortic nodes in gynecologic cancer.
- IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection.
- Integrated Chromosome 19 Transcriptomic and Proteomic Data Sets Derived from Glioma Cancer Stem-Cell Lines.
- Mesenchymal Differentiation Mediated by NF-κB Promotes Radiation Resistance in Glioblastoma.
- A high Notch pathway activation predicts response to γ secretase inhibitors in proneural subtype of glioma tumor initiating cells.
- Acquired Resistance to Anti-VEGF Therapy in Glioblastoma Is Associated with a Mesenchymal Transition.
- Novel HSP90 Inhibitor NVP-HSP990 Targets Cell-Cycle Regulators to Ablate Olig2-Positive Glioma Tumor-Initiating Cells.
- Galectin-7 levels predict radiation response in squamous cell carcinoma of the cervix.
- Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non-Small-Cell Lung Cancer.
- Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis.
- Chromosome 19 annotations with disease speciation: a first report from the Global Research Consortium.
- Tumor Prognostic Factors and the Challenge of Developing Predictive Factors.
- Validation of Recursive Partitioning Analysis and Diagnosis-Specific Graded Prognostic Assessment in patients treated initially with radiosurgery alone.
- Predictors of Survival in Contemporary Practice After Initial Radiosurgery for Brain Metastases.
- The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma.
- Management of Brain Metastasis: Past Lessons, Modern Management, and Future Considerations.
- Discovering functional modules by identifying recurrent and mutually exclusive mutational patterns in tumors.
- Multigene sets for clinical application in glioma.
- Tumor profiling: development of prognostic and predictive factors to guide brain tumor treatment.
- MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma.
- A multigene predictor of outcome in glioblastoma.
- Beyond grade: molecular pathology of malignant gliomas.
- IMRT reirradiation of head and neck cancer-disease control and morbidity outcomes.
- Intrathoracic patterns of failure for non-small-cell lung cancer with positron-emission tomography/computed tomography-defined target delineation.
- Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma.
- Systematic evaluation of map quality: human chromosome 22.
- The use of global profiling in biomarker development for gliomas.
- Bayesian ensemble methods for survival prediction in gene expression data.
- The transcriptional network for mesenchymal transformation of brain tumours.
- Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma.
- Bagged gene shaving for the robust clustering of high-throughput data.
- Exclusion of elective nodal irradiation is associated with minimal elective nodal failure in non-small cell lung cancer.
- Cancer stem cells: markers or biomarkers?
- Genomic annotation of the meningioma tumor suppressor locus on chromosome 1p34.
- A comprehensive view of human chromosome 1.
- Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children's Ca...
- Identification of a 1-megabase consensus region of deletion at 1p36.3 in primary neuroblastomas.
- BIN1 inhibits colony formation and induces apoptosis in neuroblastoma cell lines with MYCN amplification.
- Detailed molecular analysis of 1p36 in neuroblastoma.
- Prognostic and predictive markers in glioma and other neuroepithelial tumors.
Schools
Temple University
Albert Einstein Med Center
University of Texas MD Anderson Cancer Center
Procedures Preformed
- Stereotactic Radiosurgery, Spinal
Doctors Specialties
- Radiation Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- Blue Choice
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Choice Care PPO
- Medicare MCR
- MHealth Insured
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
University of Texas MD Anderson Cancer Center -
Albert Einstein Healthcare Network -
Temple University School of Medicine
Hospital
-
University of Texas M.D. Anderson Cancer Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1922261171 |
| Last Name Of The Provider | SULMAN |
| First Name Of The Provider | ERIK |
| View All |
Similar Doctors
|
|
Dr. Adam S. Garden, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Beth M. Beadle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David R. Grosshans, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gary B. Gunn, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adeel Kaiser, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Gary R. Leach, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert D. Lindberg, MD |
|
|
Dr. Cuong Q. Phan, MD |
|
|
Dr. Jing Li, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Timothy D. Wagner, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Usama Mahmood, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brian J. Deegan, MD |
|
|
Dr. Angela W. Zhu, MD
This Doctor is OpenDoctor Recommended.
|